Omega-3 fatty acids (found in fish oil supplements) were not associated with a reduction in cardiovascular (CV) events or cancers, results of the newly published manuscript of the VITAL study indicated.
The initial results of VITAL were presented at the American Heart Association 2018 Scientific Sessions in Chicago. The full results were published in current issue of the New England Journal of Medicine. The authors, using a two-by-two factorial trial design, looked at both omega-3 fatty acids and vitamin D for the primary prevention of cardiovascular events and cancers. The primary study endpoints included a combined major cardiovascular event endpoint (including myocardial infarction, stroke or death from CV causes) and invasive cancers of any type. The study researchers for the study enrolled more than 25,000 patients (n=25,871) in the study. Mean follow-up was 5.3 years.
#NutritionPharmacology
Supplements, even omega-3's, can't undo the damage of a bad diet. The diseases of metabolic syndrome are not due to deficiency, they are due to mitochondrial overload. How to stop the overload? Cut the refined carbohydrate and… https://t.co/zevTK2CPUj— Chadwick Digo (@ChadDigo) January 7, 2019